Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

MiNK Selected For ARPA-H Program To Advance Room-Temperature Cell Therapy

(RTTNews) - Wednesday, MiNK Therapeutics (INKT) said its agenT-797 iNKT cell therapy platform was selected for an ARPA-H-funded initiative aimed at enabling room-temperature storage and transport of cell therapies.

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

Read the original at nasdaq.com →

More in Finance & Markets

More from Wednesday 30 September →